Topics and Trends in Most Cited Atrial Fibrillation Management and Outcomes Papers

At a glance

Field

Atrial Fibrillation Management and Outcomes

Cohort label

Class of 2026 (2024 publications)

Papers analyzed

10,304

Papers ranked

20

Top topics in ranked papers

Pulsed field ablation, catheter ablation, pulmonary vein isolation, radiofrequency ablation, CHA2DS2-VASc score

Publication window

Jan 1, 2024 – Dec 31, 2024

Eligibility

Research articles; reviews excluded

Citation window

18 months post-publication

18m citation range

58–1,901

Data source

OpenAlex · Retrieved Jul 2026

License

CC BY 4.0

Rankings

20 papers ranked by 18-month citation count

Topic trends

Dominant research themes and year-over-year shifts in Atrial Fibrillation Management and Outcomes

What Topics Define the Class of 2026?

The informative word cloud across the 50 highest 18-month-cited atrial fibrillation management and outcomes papers reveals a field organized around ablation technology competition, procedural endpoints, and stroke-risk stratification rather than generic disease labels. Pulsed field ablation leads at 17 of 50 papers (normalized frequency 0.34), closely followed by catheter ablation (16 papers, 0.32) and pulmonary vein isolation (15 papers, 0.30)—a trio that frames how influential 2024 publications benchmark emerging energy modalities against established catheter-based isolation strategies. Radiofrequency ablation remains highly visible (10 papers, 0.20), alongside cryoballoon ablation, pentaspline ablation catheter, hybrid ablation, and surgical ablation, underscoring sustained citation weight for comparative ablation trials and device-specific outcomes. A parallel cluster centers on anticoagulation and thromboembolic risk: CHA2DS2-VASc score (9 papers, 0.18), direct oral anticoagulants, major bleeding, and left atrial appendage occlusion appear alongside rhythm-control vocabulary such as electrical cardioversion, blanking period, and atrial fibrillation burden. Mid-sized terms highlight AF subtype framing—paroxysmal and persistent atrial fibrillation—alongside recurrence, drug-refractory disease, and ambulatory ECG monitoring. Smaller but visible concepts—including incident atrial fibrillation, atrial fibrillation screening, wearable single-lead ECG monitoring, and female sex as a stroke risk factor—signal growing emphasis on population detection, sex-specific risk, and longitudinal cohort evidence alongside procedural innovation.

How Did Topics Shift from the Class of 2025 to the Class of 2026?

Comparing normalized concept frequencies between the Class of 2025 (2023 publications) and Class of 2026 (2024 publications) cohorts shows a reorientation of early-high-impact research priorities within atrial fibrillation management. Incident atrial fibrillation exhibited one of the largest gains (+0.08 normalized frequency; 1 versus 5 papers), followed by surgical ablation (+0.08; 1 versus 5) and hybrid ablation (+0.06; 1 versus 4), with additional increases for radiofrequency ablation (+0.04), CHA2DS2-VASc score (+0.04), electrical cardioversion (+0.04), and atrial fibrillation burden (+0.02). The topic evolution card underscores that Class of 2026 bars extend furthest for pulsed field ablation, catheter ablation, pulmonary vein isolation, and radiofrequency ablation—topics aligned with head-to-head ablation technology trials and updated guideline consensus. Conversely, several themes prominent in the Class of 2025 cohort receded: paroxysmal atrial fibrillation (−0.10), atrial fibrillation recurrence (−0.10), arrhythmia-free survival (−0.10), antiarrhythmic drug therapy (−0.08), repeat ablation (−0.06), persistent atrial fibrillation (−0.06), left atrial appendage occlusion (−0.06), and major bleeding (−0.06). Direct oral anticoagulants (−0.04) and pulmonary vein isolation (−0.04) also declined modestly in relative prominence. Together, these shifts suggest that the most-cited 2024 papers emphasize next-generation ablation modalities, incident-AF epidemiology, and expanded surgical-hybrid options, while paroxysmal-AF subtype framing and recurrence-centric procedural endpoints lost ground among early-high-impact work.

Cite this ranking

Pepkio Research Index (PRI). Topics and Trends in Most Cited Atrial Fibrillation Management and Outcomes Papers, Class of 2026. https://pri.pepkio.com/top-papers/atrial-fibrillation-management-and-outcomes/2026. Accessed 2026-07-13.

Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459